VSSPY yields 13.95% · MRK yields 2.81%● Live data
📍 VSSPY pulled ahead of the other in Year 1
Combined, VSSPY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VSSPY + MRK for your $10,000?
Valid Soluções S.A. provides security printing services for payment and mobile solutions, identity solutions, digital marketing, and digital certification worldwide. It operates through Means of Payment, Identification, and Mobile segments. The Means of Payment segment offers integrated products and solutions, such as chip and magnetic stripe cards, gift cards, check printing, invoices, and bank statements, as well as solutions in radio frequency identification, contactless cards, and mobile payments. The Identification segment provides physical and electronic solutions, such as data collection, storage and management, security prints, recognition, and digital printing. Its solutions are used in the generation of computerized systems for the administration of databases, collection of biometric data, printing and customization of official identification documents, solutions for smart cities, and traceable stamps. The Mobile segment offers services of issuing statements and technologies for use in cell phones, and digital mobility, such as NFC, TSM, and HCE solutions for mobile service providers. It also develops technologies for use in cell phones, such as recharge and payment and production of cards intended for telecommunications. The company serves state governments and government agencies, large financial institutions, telecommunications companies, retailers, agriculture cooperatives, and self-employed professionals. The company was formerly known as Valid Soluções e Serviços de Segurança em Meios de Pagamento e Identificação S.A. and changed its name to Valid Soluções S.A. in August 2018. Valid Soluções S.A. was founded in 1957 and is headquartered in Rio de Janeiro, Brazil.
Full VSSPY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.